Gut microbiota-considered pharmacotherapeutic management of hepatocellular carcinoma.
INTRODUCTION Treatment efficacy for hepatocellular carcinoma (HCC) remains limited. Increasing evidence indicates that gut microbiota may influence treatment response, toxicity and clinical outcomes. AREAS COVERED Our review synthesizes recent literature from PubMed and Wiley Online Library regarding gut microbiota,...